Interactions between the TGF-β/Smad4 pathway and other signaling cascades like MAP kinase, PI3K/Akt/mTOR, and WNT/β-catenin are particularly significant in tumor formation and progression, pointing to Smad4 as a potential target for cancer therapies [10]. Here, SMAD4 is linked to neoplasm.